With New Around-the-Clock Axes, clariti® 1 day toric Will Offer More Prescription Options Than Any Other
Silicone Hydrogel 1-Day Toric Contact Lens
PLEASANTON, Calif., October 23 2019 — Giving eye care professionals the opportunity to fit an even greater number of astigmatic patients in a silicone hydrogel 1-day contact lens, CooperVision, Inc. has announced expanded prescriptions for its clariti® 1 day toric. In mid-December, the lenses will be available in around-the-clock axes1, and with the addition of axes in the -2.25 cylinder power and plus powers in Spring 2020, clariti® 1 day toric’s prescription options will expand by nearly 50 percent.2
“CooperVision is known worldwide for toric contact lens innovation and performance. This latest range extension illustrates our commitment to providing a wide range of stable,3 comfortable silicone hydrogel 1-day toric options, allowing as many astigmatic patients as possible to be fit,” said Michele Andrews, OD, Senior Director, North America Professional and Academic Affairs, CooperVision. “From sphere to toric to multifocal, and in every modality, CooperVision continues to offer the industry’s broadest range of soft contact lenses, allowing today’s practitioners to meet the unique vision correction needs of virtually any patient.4”
CooperVision’s clariti® 1 day toric lenses feature a high-precision design that delivers exceptional optical performance and consistent correction of astigmatism. The lenses also provide excellent rotational stability, with nearly 100 percent of lenses stabilizing within 10° or less from the optimum position in three minutes from dispensing.3 clariti® 1 day toric silicone hydrogel contact lenses deliver up to 3x the oxygen transmissibility of some leading 1-day toric hydrogel contact lenses,5 so patients receive 100 percent of the oxygen that their corneas need.
Eye care professionals will be able to fit a greater number of 1-day toric patients in clariti® 1 day toric with the addition of the following prescriptions (in bold):
|
Sphere Power (DS) |
Cylinder Power (DC) |
Axes ° |
|---|---|---|
|
Plano to -6.00 |
-0.75, -1.25, -1.75 |
10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 110, 120, 130, 140, 150, 160, 170, 180 (axes in bold available mid-December 2019) |
| -2.25 |
10, 20, 70, 80, 90, 100, 110, 160, 170 and 180 (axes in bold available in Spring 2020) |
|
|
-6.50 to -9.00 |
-0.75, -1.25, -1.75 |
10, 20, 60, 70, 80, 90, 100, 110, 120, 160, 170, 180 |
|
-2.25 |
10, 20, 90, 160, 170 and 180 |
|
|
+0.25 to +4.00 |
-0.75, -1.25, -1.75 |
10, 20, 70, 80, 90, 100, 110, 160, 170, 180 (axes in bold available in Spring 2020) |
To help streamline the fitting process and minimize chair time, CooperVision also offers the OptiExpert™ fitting app. The easy-to-use app includes a toric calculator which calculates and suggests the recommended diagnostic CooperVision toric contact lens for your patient. OptiExpert has already been downloaded more than 30,000 times in the U.S. since being launched in November 2018.
For more information about clariti® 1 day toric, visit claritiGivesYouMore.com, and for more information about OptiExpert, visit GetOptiExpert.com.
1 Around the clock axis in 10° from Plano to -6.00DS in -0.75DC, 1.25DC and -1.75DC.
2 CVI data on file 2019.
3 Data on file, 2018. Clinical performance study with clariti 1 day toric in UK, 1-week, n=36. Within 3 minutes of dispensing and at follow-up.
4 CooperVision Data on File 2019. Based on Rx option combinations (sph, cyl, axis & ADD) manufactured, across all soft lenses in sphere, toric & multifocal (including made to order), in SiHy and hydrogel from 4 main manufacturers. Includes 1-Day, 2 weekly, and monthly disposable contact lenses. Cosmetic & Photochromatic contact lenses not included. Multiple base curve variants not included.
5 Based on manufacturer’s published data. clariti® 1 day has Dk/t of 86. Compared to Proclear 1 day (Dk/t 28), 1-day Acuvue Moist (Dk/t 33.3), Dailies Aquacomfort Plus (Dk/t 26) and Biotrue ONEday (Dk/t) 42).
# # #
About CooperVision
CooperVision, a unit of The Cooper Companies, Inc. (NYSE:COO), is one of the world’s leading manufacturers of soft contact lenses. The Company produces a full array of monthly, two-week and daily disposable contact lenses, all featuring advanced materials and optics. CooperVision has a strong heritage of solving the toughest vision challenges such as astigmatism and presbyopia; and offers the most complete collection of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit www.coopervision.com.
About The Cooper Companies
CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, Calif., Cooper has more than 12,000 employees with products sold in over 100 countries. For more information, please visit www.coopercos.com.
Media Contact
Heather Kowalczyk, APR
McDougall Communications for CooperVision, Inc.
heather@mcdougallpr.com or +1-585-434-2153